Study Stopped
Difficulty in enrolling participants
Overactive Bladder (OAB) Drink Advice Study
Prospective Intervention Study of Drink Advice in Overactive Bladder Syndrome (OAB)
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The researchers want to investigate how fluid intake influences the symptoms of OAB. The researchers will recruit 45 patients with OAB and randomize them (blind) in 3 groups (low/normal/high fluid intake). Patients will follow this drink pattern for 2-5 days, while filling in an standard micturation diary for 2 days. This micturation diary is coupled to: collection of multiple urine samples, urine pH measurements, and a Perception of Intensity of Urgency Scale (PPIUS) scoring table. All this is collected by the patients themselves. Urine samples will be analysed for osmolality by the clinical chemistry department.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
September 22, 2009
CompletedFirst Posted
Study publicly available on registry
September 23, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedJuly 24, 2012
September 1, 2009
1.4 years
September 22, 2009
July 23, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
urine osmolality
2 days
PPIUS urge-score
2 days
Secondary Outcomes (2)
urine pH
2 days
PPIUS urge score
2 days
Study Arms (3)
normal fluid intake
ACTIVE COMPARATOR1500 ml /day (+/- 300 ml) for 2,5 days
high fluid intake
ACTIVE COMPARATOR2400 ml/day (+/- 300 ml )for 2,5 days
low fluid intake
ACTIVE COMPARATORfluid intake 900 ml/day (+/- 300ml) for 2,5 days
Interventions
drinking water / normal dietary fluids for oral intake
Eligibility Criteria
You may qualify if:
- OAB patients
You may not qualify if:
- benign prostatic hyperplasia
- neurogenic detrusor overactivity
- urine tract infection
- anticholinergics
- intravesical botulin toxin
- cardiac failure
- renal insufficiency
- sacral neurostimulation
- percutaneous neurostimulation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dept. of Urology, Radboud University Nijmegen Medical Centre
Nijmegen, Gelderland, 6500 HB, Netherlands
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
John Heesakkers, dr. MD
dept of Urology, Radboud University Nijmegen Medical Centre
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 22, 2009
First Posted
September 23, 2009
Study Start
July 1, 2009
Primary Completion
December 1, 2010
Last Updated
July 24, 2012
Record last verified: 2009-09